Vantage Investment Advisors’s Avanos Medical AVNS Stock Holding History

Vantage Investment Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$0	Hold	2	–	–	﹤0.01%	768
2018 Q2	$0	Sell	2 -63	-97%	-$3.33K	﹤0.01%	762
2018 Q1	$3K	Buy	65 +2	+3%	+$95	﹤0.01%	696
2017 Q4	$3K	Buy	+63	New	+$2.9K	﹤0.01%	720
2017 Q2	–	Sell	-25	Closed	-$1K	–	772
2017 Q1	$1K	Sell	25 -56	-69%	-$2.18K	﹤0.01%	729
2016 Q4	$3K	Hold	81	–	–	﹤0.01%	670
2016 Q3	$3K	Hold	81	–	–	﹤0.01%	647
2016 Q2	$3K	Buy	81 +44	+119%	+$1.35K	﹤0.01%	672
2016 Q1	$1K	Hold	37	–	–	﹤0.01%	744
2015 Q4	$1K	Sell	37 -89	-71%	-$2.77K	﹤0.01%	728
2015 Q3	$4K	Sell	126 -28	-18%	-$977	﹤0.01%	644
2015 Q2	$6K	Sell	154 -305	-66%	-$13.7K	﹤0.01%	574
2015 Q1	$23K	Buy	459 +211	+85%	+$9.77K	0.01%	466
2014 Q4	$11K	Buy	+248	New	+$9.74K	0.01%	478

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Vantage Investment Advisors's AVNS Position: Q3 2018 in Review

Vantage Investment Advisors held its Avanos Medical (AVNS) position steady in Q3 2018 at 2 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #768.

Vantage Investment Advisors first reported a position in AVNS in Q4 2014 and has held it in 14 quarters since. The position peaked at $23K in Q1 2015. 387 funds tracked by Wall St. Rank hold AVNS as of Q3 2018.

Vantage Investment Advisors held 2 shares of Avanos Medical worth $0 as of Q3 2018.
Vantage Investment Advisors left its Avanos Medical share count unchanged in Q3 2018.
Avanos Medical made up ﹤0.01% of Vantage Investment Advisors's portfolio in Q3 2018, its #768 holding.
Vantage Investment Advisors first reported a position in Avanos Medical in Q4 2014 and has held it in 14 quarters since.
Vantage Investment Advisors's Avanos Medical position peaked at $23K in Q1 2015.
387 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2018.

Based on Vantage Investment Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.